Predictors of Study Attrition in a Randomized Controlled Trial Evaluating a Perinatal Home-Visiting Program with Mothers with Psychosocial Vulnerabilities |
journalArticle |
2015 |
Foulon, S.; Greacen, T.; Pasquet, B.; Dugravier, R.; Saias, T.; Guedeney, N.; Guedeney, A.; Tubach, F.; Group, Capedp Study |
Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival |
journalArticle |
2015 |
Kapetanakis, N. I.; Uzan, C.; Jimenez-Pailhes, A. S.; Gouy, S.; Bentivegna, E.; Morice, P.; Caron, O.; Gourzones-Dmitriev, C.; Le Teuff, G.; Busson, P. |
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study |
journalArticle |
2015 |
Libé, R.; Borget, I.; Ronchi, C. L.; Zaggia, B.; Kroiss, M.; Kerkhofs, T.; Bertherat, J.; Volante, M.; Quinkler, M.; Chabre, O.; Bala, M.; Tabarin, A.; Beuschlein, F.; Vezzosi, D.; Deutschbein, T.; Borson-Chazot, F.; Hermsen, I.; Stell, A.; Fottner, C.; Leboulleux, S.; Hahner, S.; Mannelli, M.; Berruti, A.; Haak, H.; Terzolo, M.; Fassnacht, M.; Baudin, E. |
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma |
journalArticle |
2015 |
Diouf, M.; Bonnetain, F.; Barbare, J. C.; Bouche, O.; Dahan, L.; Paoletti, X.; Filleron, T. |
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up |
journalArticle |
2015 |
Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S. |
Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma |
journalArticle |
2015 |
Tejera-Vaquerizo, A.; Nagore, E.; Puig, S.; Robert, C.; Saiag, P.; Martin-Cuevas, P.; Gallego, E.; Herrera-Acosta, E.; Aguilera, J.; Malvehy, J.; Carrera, C.; Cavalcanti, A.; Rull, R.; Vilalta-Solsona, A.; Lannoy, E.; Boutros, C.; Benannoune, N.; Tomasic, G.; Aegerte, P.; Vidal-Sicart, S.; Palou, J.; Alos, L. L.; Requena, C.; Traves, V.; Pla, A.; Bolumar, I.; Soriano, V.; Guillen, C.; Herrera-Ceballos, E. |
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial |
journalArticle |
2015 |
van den Berg, H.; Paulussen, M.; Le Teuff, G.; Judson, I.; Gelderblom, H.; Dirksen, U.; Brennan, B.; Whelan, J.; Ladenstein, R. L.; Marec-Berard, P.; Kruseova, J.; Hjorth, L.; Kuhne, T.; Brichard, B.; Wheatley, K.; Craft, A.; Juergens, H.; Gaspar, N.; Le Deley, M. C.; Euro, Ewing Group |
INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES |
journalArticle |
2015 |
Martelli, N.; Billaux, M.; Borget, I.; Pineau, J.; Prognon, P.; van den Brink, H. |
A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty |
journalArticle |
2015 |
Martelli, N.; Devaux, C.; van den Brink, H.; Pineau, J.; Prognon, P.; Borget, I. |
High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting |
journalArticle |
2015 |
Antoun, S.; Bayar, A.; Ileana, E.; Laplanche, A.; Fizazi, K.; di Palma, M.; Escudier, B.; Albiges, L.; Massard, C.; Loriot, Y. |
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours |
journalArticle |
2015 |
Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X. |
The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France |
journalArticle |
2015 |
Scotte, F.; Martelli, N.; Vainchtock, A.; Borget, I. |
Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies |
journalArticle |
2015 |
Sze, H.; Blanchard, P.; Ng, W. T.; Pignon, J. P.; Lee, A. W. |
Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx |
journalArticle |
2015 |
Gorphe, P.; Blanchard, P.; Breuskin, I.; Temam, S.; Tao, Y.; Janot, F. |
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival |
journalArticle |
2015 |
dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G. |
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer |
journalArticle |
2015 |
Pailler, E.; Auger, N.; Lindsay, C. R.; Vielh, P.; Islas-Morris-Hernandez, A.; Borget, I.; Ngo-Camus, M.; Planchard, D.; Soria, J. C.; Besse, B.; Farace, F. |
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer |
journalArticle |
2015 |
Nascimento, C.; Borget, I.; Al Ghuzlan, A.; Deandreis, D.; Hartl, D.; Lumbroso, J.; Berdelou, A.; Lepoutre-Lussey, C.; Mirghani, H.; Baudin, E.; Schlumberger, M.; Leboulleux, S. |
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma |
journalArticle |
2015 |
Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E. |
[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB] |
journalArticle |
2015 |
Ezzalfani, M.; Dugue, A.; Mollevi, C.; Pulido, M.; Bonnetain, F.; Filleron, T.; Gal, J.; Gauthier, M.; Le Deley, M. C.; Le Tourneau, C.; Medioni, J.; Nguyen, J. M.; Chabaud, S.; Teixeira, L.; Thivat, E.; You, B.; Kramar, A.; Paoletti, X. |
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study |
journalArticle |
2015 |
Vale, C. L.; Rydzewska, L. H.; Rovers, M. M.; Emberson, J. R.; Gueyffier, F.; Stewart, L. A.; Cochrane, I. P. D. Meta-analysis Methods Group |
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives |
journalArticle |
2015 |
Mirghani, H.; Amen, F.; Blanchard, P.; Moreau, F.; Guigay, J.; Hartl, D. M.; Lacau St Guily, J. |
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor |
journalArticle |
2015 |
Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F. |
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead |
journalArticle |
2015 |
Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C. |
Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy |
journalArticle |
2015 |
Blanchard, P.; Bakkour, M.; De Crevoisier, R.; Levy, A.; Baumert, H.; Patard, J. J.; Wibault, P.; Fizazi, K.; Bossi, A. |
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite |
journalArticle |
2015 |
Grünewald, T. G.; Bernard, V.; Gilardi-Hebenstreit, P.; Raynal, V.; Surdez, D.; Aynaud, M. M.; Mirabeau, O.; Cidre-Aranaz, F.; Tirode, F.; Zaidi, S.; Perot, G.; Jonker, A. H.; Lucchesi, C.; Le Deley, M. C.; Oberlin, O.; Marec-Bérard, P.; Véron, A. S.; Reynaud, S.; Lapouble, E.; Boeva, V.; Rio Frio, T.; Alonso, J.; Bhatia, S.; Pierron, G.; Cancel-Tassin, G.; Cussenot, O.; Cox, D. G.; Morton, L. M.; Machiela, M. J.; Chanock, S. J.; Charnay, P.; Delattre, O. |
Precision medicine: lessons learned from the SHIVA trial - Authors' reply |
journalArticle |
2015 |
Le Tourneau, C.; Belin, L.; Paoletti, X.; Bieche, I.; Kamal, M. |
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial |
journalArticle |
2015 |
Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M. |
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma |
journalArticle |
2015 |
Izzedine, H.; Derosa, L.; Le Teuff, G.; Albiges, L.; Escudier, B. |
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis |
journalArticle |
2015 |
Blanchard, P.; Lee, A.; Marguet, S.; Leclercq, J.; Ng, W. T.; Ma, J.; Chan, A. T.; Huang, P. Y.; Benhamou, E.; Zhu, G.; Chua, D. T.; Chen, Y.; Mai, H. Q.; Kwong, D. L.; Cheah, S. L.; Moon, J.; Tung, Y.; Chi, K. H.; Fountzilas, G.; Zhang, L.; Hui, E. P.; Lu, T. X.; Bourhis, J.; Pignon, J. P.; Group, Mac-Npc Collaborative |
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials |
journalArticle |
2015 |
Paoletti, X.; Ezzalfani, M.; Le Tourneau, C. |
Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome |
journalArticle |
2015 |
Patrikidou, A.; Brureau, L.; Casenave, J.; Albiges, L.; Di Palma, M.; Patard, J. J.; Baumert, H.; Blanchard, P.; Bossi, A.; Kitikidou, K.; Massard, C.; Fizazi, K.; Blanchet, P.; Loriot, Y. |
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases |
journalArticle |
2015 |
de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. |
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study) |
journalArticle |
2015 |
Raynaud, C.; Greillier, L.; Mazieres, J.; Monnet, I.; Mastroianni, B.; Robinet, G.; Fraboulet, G.; Dixmier, A.; Berard, H.; Lamy, R.; Letreut, J.; Lena, H.; Oliviero, G.; Botta, S.; Vergnenegre, A.; Borget, I.; Chouaid, C. |
[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management] |
journalArticle |
2015 |
Luporsi, E.; Bellocq, J. P.; Barrière, J.; Bonastre, J.; Chetritt, J.; Le Corroller, A. G.; de Cremoux, P.; Fina, F.; Gauchez, A. S.; Lamy, P. J.; Martin, P. M.; Mazouni, C.; Peyrat, J. P.; Romieu, G.; Verdoni, L.; Mazeau-Woynar, V.; Kassab-Chahmi, D. |
Nail toxicities induced by systemic anticancer treatments |
journalArticle |
2015 |
Robert, C.; Sibaud, V.; Mateus, C.; Verschoore, M.; Charles, C.; Lanoy, E.; Baran, R. |
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival |
journalArticle |
2015 |
dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G. |
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial |
journalArticle |
2015 |
Levy, A.; Azria, D.; Pignon, J. P.; Delarochefordiere, A.; Martel-Lafay, I.; Rio, E.; Malka, D.; Conroy, T.; Miglianico, L.; Becouarn, Y.; Malekzadeh, K.; Leclercq, J.; Juzyna, B.; Ezra, P.; Lemanski, C.; Deutsch, E. |
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al |
journalArticle |
2015 |
de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. |
Nail toxicities induced by systemic anticancer treatments |
journalArticle |
2015 |
Robert, C.; Sibaud, V.; Mateus, C.; Verschoore, M.; Charles, C.; Lanoy, E.; Baran, R. |
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia |
journalArticle |
2015 |
Selimoglu-Buet, D.; Wagner-Ballon, O.; Saada, V.; Bardet, V.; Itzykson, R.; Bencheikh, L.; Morabito, M.; Met, E.; Debord, C.; Benayoun, E.; Nloga, A. M.; Fenaux, P.; Braun, T.; Willekens, C.; Quesnel, B.; Ades, L.; Fontenay, M.; Rameau, P.; Droin, N.; Koscielny, S.; Solary, E.; Francophone Myelodysplasia, Group |